Search Results
Aug 25, 2026, 10:00 ET Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-1866 Investigational Therapy for Pitt Hopkins Syndrome
biotechnology company developing precision therapies for neurogenetic disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to MZ-1866, Mahzi's investigational gene therapy for the treatment of Pitt Hopkins syndrome. The designation was
More news about: MAHZI Therapeutics
Aug 25, 2026, 10:00 ET PCORI awards funding for new patient-centered healthcare research to inform healthcare decisions
care and address a range of health concerns including cancer, cardiovascular disease, mental and behavioral health, women's health, pediatric care, rare diseases and chronic disease management.Every day in the United States, people make decisions with insufficient information about which treatments
More news about: Patient-Centered Outcomes Research Institute
Aug 25, 2026, 10:00 ET U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies,
More news about: Jazz Pharmaceuticals plc
Aug 25, 2026, 09:31 ET Precisely nommé leader dans le rapport IDC MarketScape : Worldwide Data Intelligence Platform Software 2026 Vendor Assessment
entre elles et avec celles d'autres fournisseurs de premier plan via le programme Data Link. Cette couche de contexte géospatial issue du monde réel est rare parmi les plateformes d'intelligence des données. Elle est accessible via un catalogue de données robuste offrant une large connectivité aux métadonnées,
More news about: Precisely Software Limited
Aug 25, 2026, 09:00 ET Precisely Named a Leader in IDC MarketScape: Worldwide Data Intelligence Platform Software 2026 Vendor Assessment
properties, risks, and streets prelinked to one another and other leading providers through the Data Link program. This real-world geospatial context layer is rare among data intelligence platforms and is surfaced through a robust data catalog with broad metadata connectivity, intuitive search and discovery, AI-driven
More news about: Precisely Software Limited
Aug 25, 2026, 09:00 ET Precisely Named a Leader in IDC MarketScape: Worldwide Data Intelligence Platform Software 2026 Vendor Assessment
properties, risks, and streets prelinked to one another and other leading providers through the Data Link program. This real-world geospatial context layer is rare among data intelligence platforms and is surfaced through a robust data catalog with broad metadata connectivity, intuitive search and discovery, AI-driven
More news about: Precisely Software Limited
Aug 25, 2026, 08:44 ET Switch Bioworks Names Gordana M. Djordjevic Chief Scientific Officer, Adds Eric Bartels to Advisory Board
biological insight with a strong understanding of what it will take for microbial products to succeed in the market," said Bartels. "That combination is rare at this stage. I look forward to helping this team get its science out of the lab and into the field."Switch obtained USDA and EPA authorization
More news about: Switch Bioworks
Aug 25, 2026, 08:44 ET Fosun Pharma Announces 2026 Interim Results
oncology, immunology and inflammation, and neurodegenerative diseases. It also expands into CVRM (cardiovascular, renal and metabolic), anti-infectives, rare diseases and other segments. Leveraging an open-innovation framework that combines in-house R&D, two-way licensing and fund-incubation models, the
More news about: Fosun Pharma
Aug 25, 2026, 08:30 ET Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
for the 16-week induction period were consistent with the previously observed and reported safety profile.1-3 Serious adverse events were rare (2%), with no deaths reported during the 16-week induction period and no increased risk of infections, conjunctivitis, or other safety signals associated
More news about: Nektar Therapeutics
Aug 25, 2026, 08:03 ET Netcraft Appoints Cybersecurity Industry Veteran Darren Lee to Board of Directors
expand their solutions that help security leaders take decisive action to stop cybercrime."Ryan Woodley, CEO, Netcraft, said: "Darren has a rare perspective in cybersecurity, as he has built companies as an entrepreneur and then helped scale one of the industry's most successful security businesses
More news about: Netcraft
Aug 25, 2026, 08:00 ET Harry Winston 珠寶世家呈獻「Rare Jewels of the World」展覽
全新高級珠寶及時計展覽於中國上海舉行上海2026年8月25日 /美通社/ -- 被譽為「鑽石之王」的傳奇珠寶及時計品牌 Harry Winston，今日在中國上海呈獻「Rare Jewels of the World」高級珠寶及時計展覽。展覽將於 9 月 7 日至 13 日向公眾開放，呈獻品牌的傳奇寶石、獨一無二的高級珠寶作品、典藏珍品及時計傑作。
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET The House of Harry Winston Presents "Rare Jewels of the World"
/PRNewswire/ -- The House of Harry Winston, the legendary jewelry and timepiece brand renowned as the "King of Diamonds," presents its magnificent "Rare Jewels of the World" High Jewelry and Timepiece Exhibition in Shanghai, China. Open to the public from September 7 to 13, the new exhibition will
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET The House of Harry Winston Presents "Rare Jewels of the World"
/PRNewswire/ -- The House of Harry Winston, the legendary jewelry and timepiece brand renowned as the "King of Diamonds," presents its magnificent "Rare Jewels of the World" High Jewelry and Timepiece Exhibition in Shanghai, China. Open to the public from September 7 to 13, the new exhibition will
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET The House of Harry Winston presenta "Rare Jewels of the World"
Winston, il leggendario marchio di gioielli e orologi noto come "King of Diamonds", presenta la sua magnifica esposizione di alta gioielleria e orologi "Rare Jewels of the World" a Shanghai, in Cina. Aperta al pubblico dal 7 al 13 settembre, la nuova mostra presenterà le pietre leggendarie della House,
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET La Maison Harry Winston présente « Rare Jewels of the World »
de joaillerie et d'horlogerie réputée pour être le « roi des diamants », présente sa magnifique exposition de haute joaillerie et d'horlogerie « Rare Jewels of the World » à Shanghai, en Chine. Ouverte au public du 7 au 13 septembre, cette nouvelle exposition présentera les pierres légendaires
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET Das Haus Harry Winston präsentiert „Seltene Juwelen der Welt"
Das Haus Harry Winston, die legendäre Schmuck- und Uhrenmarke, die als „König der Diamanten" bekannt ist, präsentiert seine prächtige Ausstellung „Rare Jewels of the World" mit Haute Joaillerie und Uhren in Shanghai, China. Die neue Ausstellung ist vom 7. bis 13. September für die Öffentlichkeit
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET House of Harry Winston、「世界の希少な宝石（Rare Jewels of the World）」展を開催
https://www.harrywinston.com/zh-hans/themes/rare-jewels-of-the-world-brand-exhibition
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET La Casa Harry Winston presenta "Joyas Excepcionales del Mundo"
https://www.harrywinston.com/zh-hans/themes/rare-jewels-of-the-world-brand-exhibition
More news about: Harry Winston, Inc.
Aug 25, 2026, 08:00 ET Mend Well Launches Expanded Chronic Condition Management, Extending Surgical Care Into Long-Term Obesity and Hypertension Support
than 6,500 patients through surgery and beyond, and is now built to stay with them well after recovery ends."A surgical episode is one of the rare moments patients are highly motivated and fully engaged in their health," said Paul Roscoe, CEO of Mend. "Mend Well is built to meet patients in that
More news about: Mend Labs
Aug 25, 2026, 07:59 ET Lundbeck and EVERSANA Announce Strategic Partnership to Advance AI-Powered Commercialization
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: EVERSANA
Aug 25, 2026, 07:05 ET REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic
More news about: REGENXBIO Inc.
Aug 25, 2026, 07:00 ET BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2026 on Monday, August 31, 2026,
More news about: BioLineRx Ltd.
Aug 25, 2026, 06:24 ET CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors
Sued for Securities Fraud? Capricor is a biotechnology company focused on developing cell and exosome-based therapeutics for rare diseases. Its lead product candidate, Deramiocel, is an investigational cell therapy being developed for Duchenne muscular dystrophy.According
More news about: Bleichmar Fonti & Auld LLP
Aug 25, 2026, 06:10 ET INVESTOR DEADLINE: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 28, 2026 Deadline - BE
manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to stabilize the zirconia-based ceramic electrolyte in Bloom Energy's solid oxide fuel cells.The Bloom Energy
More news about: Robbins Geller Rudman & Dowd LLP
Aug 25, 2026, 06:00 ET Hypersonics and Critical Munitions Company Ursa Major to Go Public
demand accelerated to today's extraordinary level. That combination of technical maturity, manufacturing readiness and rapidly expanding demand is rare, and has resulted in a historically large PIPE anchored by Inflection Point," said Michael Blitzer, Chairman and Founder of Inflection Point. "This is
More news about: Ursa Major